AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Cocrystal Pharma, Inc. Director's Dealing 2023

Apr 27, 2023

35066_dirs_2023-04-27_1d8631f5-0b03-434b-97da-fad3b9409cc8.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2023-04-20

Reporting Person: Hassan Fred (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1015229	Direct